DilAtation Versus Endoscopic Laser Resection in Simple Benign trAcheal sTEnosis

NCT ID: NCT04719845

Last Updated: 2022-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-17

Study Completion Date

2025-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter randomized controlled trial comparing endoscopic laser resection vs dilatation in benign tracheal stenosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

An observational study suggests the superiority of endoscopic laser resection over dilatation in idiopathic tracheal stenosis but little litterature has been published on the subject. Hence we decided to design a prospective multicenter open label randomized controlled trial to compare the two interventions. Patients refered for endoscopic treatment of a simple benign tracheal stenosis will be randomized to endoscopic laser resection or dilatation. Randomisation will be stratified for center, type of stenosis (idiopathic vs other) and history of previous endoscopic treatment. Patients will be blinded to treatment but not physician. All patients will be treated with proton pump inhibitors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tracheal Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Controlled Trial
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endoscopic laser resection

Using CO2, diode or similar wavelenght laser the stenotic tracheal segment will be vaporized allowing a less than 20% residual stenosis. Dilatation will not be performed after laser resection for residual stenosis.

Group Type EXPERIMENTAL

Endoscopic laser resection

Intervention Type PROCEDURE

Laser resection

Dilatation

Using a ballon or rigid bronchoscope the stenotic tracheal segment will be dilated with or without previous radial incision with electrocautery or laser.

Group Type EXPERIMENTAL

Dilatation

Intervention Type PROCEDURE

Dilatation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endoscopic laser resection

Laser resection

Intervention Type PROCEDURE

Dilatation

Dilatation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Benign simple tracheal stenosis (length of stenosis \<1cm without underlying cartilage damage) with planned endoscopic treatment (first treatment or recurrence)

Exclusion Criteria

* Less than 18 years old
* Pregnant
* Incapacity to give informed consent
* Underlying inflammatory suspected to be the cause of stenosis (ex : granulomatosis with polyangitis)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marc Fortin

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marc Fortin

Role: PRINCIPAL_INVESTIGATOR

Fondation IUCPQ

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ)

Québec, , Canada

Site Status RECRUITING

Centre Hospitalier Universitaire Grenoble Alpes

Grenoble, , France

Site Status NOT_YET_RECRUITING

Hôpital Nord

Marseille, , France

Site Status NOT_YET_RECRUITING

Hôpital Larrey, University Hospital of Toulouse

Toulouse, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marc Fortin

Role: CONTACT

4186568711 ext. 5504

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marc FORTIN

Role: primary

Ihab ATALLAH

Role: primary

Hervé DUTAU

Role: primary

Nicolas Guibert

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Soumagne T, Guibert N, Atallah I, Lacasse Y, Dutau H, Fortin M. Dilation versus laser resection in subglottic stenosis: protocol for a prospective international multicentre randomised controlled trial (AERATE trial). BMJ Open. 2022 Mar 17;12(3):e053730. doi: 10.1136/bmjopen-2021-053730.

Reference Type DERIVED
PMID: 35301206 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-3573

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.